Catamount Wealth Management’s Amgen AMGN Stock Holding History

Catamount Wealth Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$51K	Buy	270 +130	+93%	+$24.8K	0.03%	87
2018 Q4	$26K	Buy	140 +2	+1%	+$390	0.02%	89
2018 Q3	$29K	Buy	138 +1	+0.7%	+$197	0.01%	107
2018 Q2	$27K	Buy	137 +1	+0.7%	+$177	0.01%	102
2018 Q1	$23K	Buy	136 +1	+0.7%	+$184	0.01%	107
2017 Q4	$24K	Buy	135 +20	+17%	+$3.54K	0.01%	108
2017 Q3	$22K	Hold	115	–	–	0.01%	111
2017 Q2	$20K	Sell	115 -21	-15%	-$3.42K	0.01%	114
2017 Q1	$22K	Buy	136 +1	+0.7%	+$166	0.02%	112
2016 Q4	$20K	Buy	135 +113	+514%	+$17K	0.02%	99
2016 Q3	$4K	Buy	+22	New	+$3.72K	﹤0.01%	130

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Catamount Wealth Management's AMGN Position: Q1 2019 in Review

Catamount Wealth Management increased its Amgen (AMGN) stake by 93% in Q1 2019, buying an estimated $24.8K and bringing the position to 270 shares worth $51K. The position accounts for 0.03% of the portfolio, ranked #87.

Catamount Wealth Management first reported a position in AMGN in Q3 2016 and has held it in 11 quarters since. 1,886 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

Catamount Wealth Management held 270 shares of Amgen worth $51K as of Q1 2019.
Catamount Wealth Management bought 130 Amgen shares in Q1 2019, an estimated $24.8K.
Amgen made up 0.03% of Catamount Wealth Management's portfolio in Q1 2019, its #87 holding.
Catamount Wealth Management first reported a position in Amgen in Q3 2016 and has held it in 11 quarters since.
1,886 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on Catamount Wealth Management's 13F filing for Q1 2019, filed 3 May 2019.